Skip to main content
. 2014 Nov 27;2014(11):CD004800. doi: 10.1002/14651858.CD004800.pub3

3.6. Analysis.

3.6

Comparison 3 Sulfasalazine versus placebo (axial form ankylosing spondylitis, end point values), Outcome 6 Patient assessment of disease severity (VAS 100 mm, 0 = very good, 100 = very poor).